SurGenTec® Achieves FDA Clearance for ION-L™ Compatible with Lumbar Navigation

Key Takeaways

The FDA has granted 510(k) clearance for SurGenTec’s ION-L™ navigation instruments, compatible with the ION-L™ Lumbar Facet Fixation System.
The system enhances precision in lumbar facet fusion procedures by assisting in accurate anatomical targeting.
Potential benefits include improved visualization, procedural control, and reductions in operative time and complications.

Advancements in Spine Surgery Technology

SurGenTec, a medical device company dedicated to orthopedic and spine surgery innovations, has announced that its ION-L™ navigation instruments received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance allows the instruments to be used in conjunction with the ION-L™ Lumbar Facet Fixation System, compatible with Medtronic’s StealthStation™ navigation platform.

The ION-L™ system is designed to enhance the precision of posterior lumbar facet fusion procedures. By allowing surgeons to accurately locate anatomical structures, specifically the lumbar facet joint, these navigation instruments support both open and minimally invasive spinal surgeries, improving implant placement and surgical workflow.

The ION-L™ implant features a zero-profile design and controlled drill-to-implant geometry, facilitating non-impact placement and ensuring accurate implant depth. This system aims to maintain the facet joint in a neutral position during insertion, thereby reducing the risk of unintended joint expansion and preserving native spinal alignment.

The potential advantages of the ION-L™ system during navigated procedures include:
– Enhanced precision in locating lumbar facets.
– Improved visualization of anatomy surrounding surgical sites.
– Increased control during surgery, boosting surgeon confidence.
– Potential decrease in operative time, radiation exposure, and surgical complications.

As navigation-assisted spine procedures become increasingly refined, the ION-L™ navigation instruments mark significant progress in enhancing lumbar spine surgery technology.

Travis Greenhalgh, CEO and Founder of SurGenTec, highlighted the importance of this FDA clearance, stating, “Navigation compatibility for ION-L™ demonstrates our continued commitment to providing advanced options for surgeons treating lumbar spine diseases requiring fixation. Previously, precision in posterior lumbar fixation relied mostly on fluoroscopic guidance and surgeon experience. Now, ION-L™ offers an additional tool for accurate and efficient placement while maintaining a minimally invasive approach.”

SurGenTec is a privately held firm focused on innovation in spine and orthopedic surgery, committed to improving clinical outcomes and addressing unmet needs in posterior lumbar fixation. The company offers a wide range of technologies, including facet fixation systems, synthetic biologics, and sacroiliac joint fixation systems. Recently, SurGenTec has expanded its global reach, establishing an international sales headquarters in Brazil, furthering its mission to drive growth and support surgical innovation worldwide.

The content above is a summary. For more details, see the source article.